| [population-based study of human papillomavirus infection in high-risk area for cervical cancer in shanxi province, china]. | to investigate the prevalence of oncogenic type of human papillomavirus (hpv) infection and identify the high risk population for conducting immuno/chemoprevention of cervical cancer. | 2003 | 12974078 |
| risk factors for hpv infection and cervical cancer among unscreened women in a high-risk rural area of china. | we report a prevalence rate of 23.6% human papillomavirus (hpv) infection with oncogenic subtypes and 2.4% cervical intraepithelial neoplasia (cin) iii and cervical cancer (cc) in rural middle-aged women in 2 counties with the highest cc mortality in shanxi province, china. we examined the association of risk factors to hpv infection and to cin iii and cc in 8,798 unscreened women aged 35-50 years. multivariate odds ratios (or) and 95% confidence intervals (ci) for each endpoint were obtained fo ... | 2006 | 16080192 |
| a new hpv-dna test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural china. | a new test (carehpv; qiagen, gaithersburg, md, usa) has been developed to detect 14 high-risk types of carcinogenic human papillomavirus (hpv) in about 2.5 h, to screen women in developing regions for cervical intraepithelial neoplasia (cin). we did a cross-sectional study to assess the clinical accuracy of carehpv as a rapid screening test in two county hospitals in rural china. | 2008 | 18805733 |
| cost-effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high-risk region of china. | this study assessed the cost-effectiveness of a new, rapid human papillomavirus (hpv)-dna screening test for cervical cancer prevention in the high-risk region of shanxi, china. using micro-costing methods, we estimated the resources needed to implement preventive strategies using cervical cytology or hpv-dna testing, including the hybrid capture 2 (hc2) test (qiagen corp., gaithersburg, md) and the rapid hpv-dna carehpv test (qiagen). data were used in a previously published model and empirical ... | 2010 | 20049838 |
| the burden of cervical cancer in china: synthesis of the evidence. | the burden of cervical cancer in china has not been characterized in detail. we reviewed cervical cancer data from national mortality surveys and registries, and conducted a meta-analysis to estimate the prevalence of high-grade lesions (hsil) and high-risk human papillomavirus (hr-hpv) infections in rural shanxi province. we found that a national survey in the 1970s estimated age-standardized cervical cancer mortality rates as ôê+15 and ôê+83/100,000 women nationally and in xiangyuan, shanxi; b ... | 2011 | 21387308 |
| Tuberculosis and Oncogenic HPV: Potential Co-infections in Women at High-risk of Cervical Cancer in Rural China. | The study was embedded in Shanxi Province Cervical Cancer Screening Study II with the aim of examining the association between history of diagnosed tuberculosis or cervical inflammation and oncogenic human papillomavirus (HPV) infection, persistent oncogenic HPV infection, cervical intraepithelial neoplasia grade 3 or cervical cancer (CIN3+) in an isolated rural population of China. A total of 8,798 women were recruited for cervical cancer screening and an interviewer-administered questionnaire. ... | 2011 | 22126473 |